A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention
Abstract This meta‐analysis was performed to compare the safety, efficacy, and pharmacoeconomic of bivalirudin versus heparin in high‐risk patients for percutaneous coronary interventions (PCI). Earlier meta‐analysis comparing bivalirudin and heparin during PCI demonstrated that bivalirudin caused l...
Saved in:
Main Authors: | Ke‐Xin Sun (Author), Bin Cui (Author), Shan‐Shan Cao (Author), Wen‐Jun Wang (Author), Feng Yu (Author), Jing‐Wen Wang (Author), Yi Ding (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
by: Abdul Hafeez Ahmad Hamdi, et al.
Published: (2017) -
Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis
by: Liyao Liu, et al.
Published: (2022) -
The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
by: Min Ma, et al.
Published: (2022) -
Cost-Effectiveness Analysis of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Venous Thromboembolism in China
by: Ke-Xin Sun, et al.
Published: (2021) -
Safety and Efficacy of Bivalirudin versus Unfractionated Heparin Monotherapy in Patients with CAD and DM Undergoing PCI: A Retrospective Observational Study
by: Jing Li, et al.
Published: (2022)